Artificial venous valves: an ongoing quest to treat end-stage deep venous insufficiency
Michael C. DALSING Indiana University School of Medicine Indianapolis, USA ABSTRACT End-stage deep venous insufficiency is unrelenting venous hypertension with sequelae, and no standard option is available, or all options have been tried and found wanting. In such cases, there is an opportunity for an artificial venous valve to be used as a native valve. For decades, substitute valves have been studied experimentally, raising hope of bench-to-bedside transfer. This quest is reviewed with an emphasis on current clinical practice. Venous valves have been made entirely of non-autologous tissues: synthetics, xenografts, or allografts. Many have failed in early experimental evaluation, with…